Treatment of HCV with direct-acting antivirals on reducing mortality related to extrahepatic manifestations: a large population-based study in British Columbia, CanadaResearch in context

Summary: Background: HCV infection is associated with mortality due to extrahepatic manifestations (EHM). Sustained virologic response (SVR) following direct-acting antiviral (DAA) therapy has been linked to decreased all-cause and liver-related mortality. However, evidence regarding the impact of...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Dahn Jeong, Stanley Wong, Mohammad Ehsanul Karim, Amee R. Manges, Jean Damascene Makuza, Sofia R. Bartlett, Héctor Alexander Velásquez García, Daryl Luster, Prince Asumadu Adu, Mawuena Binka, Amanda Yu, Mel Krajden, Naveed Zafar Janjua
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Elsevier 2024-01-01
Edice:	The Lancet Regional Health. Americas
Témata:	Population-based study HCV infection Extrahepatic manifestations Mortality Direct-acting antivirals Inverse probability of treatment weighting
On-line přístup:	http://www.sciencedirect.com/science/article/pii/S2667193X23002326
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!